Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. LMT
6. RXST
7. SPGI
8. RIVN
9. SPY
10. BFH

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2019

Enanta Pharma (ENTA) Tops Q3 EPS by 17c

August 6, 2019 4:01 PM EDT

Enanta Pharma (NASDAQ: ENTA) reported Q3 EPS of $0.33, $0.17 better than the analyst estimate of $0.16. Revenue for the quarter came in at $44.4 million versus the consensus estimate of $49.98 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More